Analytical table comparing IQVIA 2Q26 actuals with the pre-print hurdle. R&D Solutions revenue beat by 2.6% and book-to-bill was 1.22x versus 1.11x, the clearest positives; Commercial Solutions revenue was approximately in line, while contracted backlog was 0.8% below consensus.